Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

Sponsor
Tan Tock Seng Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05572866
Collaborator
(none)
1,089
1
41.9
26

Study Details

Study Description

Brief Summary

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

Condition or Disease Intervention/Treatment Phase
  • Other: COVID-19 pandemic

Detailed Description

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

A comparative audit of the unit's surgical workload for the months of January-June across 2019 to 2022, which corresponded to pre-COVID-19, the height of the pandemic, and a gradual normalization of surgical services. Operations performed by the unit were collected from the surgeons' electronic case logs. These operations were sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years were compared and analysed.

No patient contact or identifiers were retrieved, stored or disseminated and thus exempt from ethics board review.

Study Design

Study Type:
Observational
Actual Enrollment :
1089 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Before and After- Impact of COVID-19 Pandemic on Hepatobiliary and Pancreatic Surgical Services in Singapore: Retrospective Quantitative Study 2019-2022
Actual Study Start Date :
Jan 1, 2019
Actual Primary Completion Date :
Jun 30, 2022
Actual Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
2019

No intervention will be carried out. The sum total of surgeries carried out during 2019 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Other: COVID-19 pandemic
To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

2020

No intervention will be carried out. The sum total of surgeries carried out during 2020 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Other: COVID-19 pandemic
To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

2021

No intervention will be carried out. The sum total of surgeries carried out during 2021 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Other: COVID-19 pandemic
To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

2022

No intervention will be carried out. The sum total of surgeries carried out during 2022 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

Other: COVID-19 pandemic
To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

Outcome Measures

Primary Outcome Measures

  1. Number of surgeries done under general anaesthesia by the hepatopancreatobiliary unit [2019-2022]

    Operations performed by the unit will be collected from the surgeons' electronic case logs. These operations will be sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years will be compared and analysed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 120 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all patients who underwent gallbladder, hernia, liver or pancreas resection surgeries during the periods of January to June of 2019/2020/2021/2022.
Exclusion Criteria:
  • anyone who does not fall within the inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tan Tock Seng Hospital Singapore Singapore 308433

Sponsors and Collaborators

  • Tan Tock Seng Hospital

Investigators

  • Study Director: Vishalkumar G Shelat, MMed, FRCS, Tan Tock Seng Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tan Tock Seng Hospital
ClinicalTrials.gov Identifier:
NCT05572866
Other Study ID Numbers:
  • ttshhpb
First Posted:
Oct 10, 2022
Last Update Posted:
Oct 10, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2022